Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC
Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC
Recruiting · NCT07126119 · Registry updated 2025-08-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC | renal pelvis/ureter urothelial carcinoma | Recruiting | Phase 2 | 2025-08-17 | NCT07126119 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tianjin Medical University Second Hospital | 50 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Second Hospital of Tianjin Medical University | Tianjin | China | 3 |